PROVIDER PROFILE · NPI 1598901316

Richard RoyalM.D.

PRACTICEMAINEHEALTHSee all providers at this practice →

Surgical OncologyPortland, MEI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

320

Unique beneficiaries

—

Total services

370

Distinct HCPCS

Medicare payment

$33K

Peer benchmark

Total Medicare services vs. 5 Surgical Oncology providers in ME — top quintile (cohort median 261).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$519

Distinct drugs

Brand share

51.3%

Top prescribed drugs

Lidocaine/Prilocaine39 claims

Tramadol Hcl37 claims

QUALITY · MIPS · 2024

Final MIPS score

97.9

Quality

83.3

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.97%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Richard Royal's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER	148	1,279
Kristi Mungovan Physician Assistant · Houston, TX	44	104
WRAY, TARA	35	145
Jeremy Erasmus Diagnostic Radiology · Houston, TX	14	26
Adi Diab Medical Oncology · Houston, TX	11	102
TETZLAFF, MICHAEL	11	72
Catherine Devine Diagnostic Radiology · Houston, TX	11	53
Phyu Aung Pathology · Houston, TX	11	22

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history